Published in Lab Business Week, March 12th, 2006
The notes and warrants were sold in a private placement to a group of investors led by SCO Capital Partners LLC.
The notes mature on March 31, 2007, are convertible into company common stock at a fixed conversion rate of $0.22 per share, bear interest of 7.5% per annum and are secured by the assets of the company. The notes may be converted at the option of the holders or the company under certain circumstances as defined in the notes.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.